NOVO NORDISK A/S |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 902.5 DKK | +2.19% |
|
+6.69% | +30.00% |
| May. 10 | Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll shows | RE |
| May. 10 | India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says | RE |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NOVO NORDISK A/S | Other Pharmaceuticals | +2.64% | +6.69% | +30.00% | +58.99% | +467.19% | 568B |  |  | |
- Stock Market
- Equities
- NOVO B Stock
- Charts Novo Nordisk A/S
- Relative Strength Chart